Editorial: Reducing mortality from cardiovascular disease among patients undergoing dialysis is a global public health challenge. The past 10 years have seen trials of many interventions designed to improve survival and cardiovascular outcomes in these patients. Unfortunately, none of these interventions has been shown to be effective, despite beneficial effects in surrogate markers. It appears that statins have now joined this group of “promising but ineffective” interventions.
- Cardiovascular disease
- kidney disease